000 | 01248 a2200337 4500 | ||
---|---|---|---|
005 | 20250514234228.0 | ||
264 | 0 | _c20050815 | |
008 | 200508s 0 0 eng d | ||
022 | _a1468-2044 | ||
024 | 7 |
_a10.1136/adc.2004.069948 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFeltes, T F | |
245 | 0 | 0 |
_aPalivizumab prophylaxis in haemodynamically significant congenital heart disease. _h[electronic resource] |
260 |
_bArchives of disease in childhood _cAug 2005 |
||
300 |
_a875-7; author reply 875-7 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aData Interpretation, Statistical |
650 | 0 | 4 |
_aHeart Defects, Congenital _xcomplications |
650 | 0 | 4 | _aHospitalization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aPalivizumab |
650 | 0 | 4 |
_aVirus Diseases _xprevention & control |
700 | 1 | _aSimoes, E | |
773 | 0 |
_tArchives of disease in childhood _gvol. 90 _gno. 8 _gp. 875-7; author reply 875-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/adc.2004.069948 _zAvailable from publisher's website |
999 |
_c15694712 _d15694712 |